The Clinical Utility of the BMD-related comprehensive Genome-wide polygenic score in identifying individuals with a high risk of osteoporotic fractures (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.11.16.22282416
Publication URI: http://dx.doi.org/10.1101/2022.11.16.22282416
Type: Preprint